Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide

Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide

Allogeneic stem cell transplantation (SCT) from an HLA-haploidentical relative provides a potentially curative treatment option for hematologic malignancies patients who lack a suitably HLA-matched donor. The greatest challenge to performing HLA-haploidentical SCT has been high rates of graft failur...

Full description

Bibliographic Details
Main Authors: Ashley Munchel, Chimen Kesserwan, Heather J. Symons, Leo Luznik, Yvette L. Kasamon, Richard J. Jones, Ephraim J. Fuchs
Format: Article
Language:English
Published: MDPI AG 2011-06-01
Series:Pediatric Reports
Online Access:https://www.pagepress.org/journals/index.php/pr/article/view/2833

Similar Items

Similar Items